Very Low Cardiac Device Infection Rates With TYRX Antibacterial Envelope Use
Kureczka/Martin Associates New prospective data presented on 1,000 patients at 2013 Heart Rhythm Society shows over 90 percent fewer major device infections Use of TYRX, Inc.'s AIGISRx® Antibacterial Envelope reduced major infection rates...
Latest Implantable cardioverter-defibrillator Stories
Even though patients receiving an implantable cardioverter-defibrillator (ICD) for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA....
A device commonly used to treat dangerous heart rhythms may cause more issues for patients than a simpler version of the same device. The implantable cardioverter-defibrillator (ICD) prevents sudden cardiac death by detecting irregularities and delivering an electrical jolt to restart the heart. AURORA, CO (PRWEB) May 14, 2013 A device commonly used to treat dangerous heart rhythms may cause more issues for patients than a simpler version of the same device. The implantable...
Programming an implantable cardioverter-defibrillator (ICD) with a long-detection interval compared with a standard-detection interval resulted in a reduction in anti-tachycardia pacing episodes, ICD shocks delivered, and inappropriate shocks, according to a study in the May 8 issue of JAMA. "Therapy with ICDs is now the standard of care in primary and secondary prevention. As indications for implants have expanded, concern about possible adverse effects of ICD therapies on prognosis and...
Arrhythmias gone in majority of children, says study to be reported at 93rd AATS Annual Meeting Inherited ventricular arrhythmias are an important cause of morbidity and sudden cardiac death in children who have structurally normal hearts. Despite conventional medical therapy, some of these children remain symptomatic with recurrent life-threatening arrhythmias, syncope, or frequent discharges from implantable cardioverter defibrillators (ICDs). Video-assisted thoracoscopic left cardiac...
InCube's San Antonio Innovation Center Expands with Medical Device Companies, Theracle and iBridge Medical SAN ANTONIO and SAN JOSE, Calif., May 2, 2013 /PRNewswire/ -- InCube Labs, a life sciences research lab focused on developing medical breakthroughs that dramatically improve patient outcomes, today announced the launch of two new life sciences companies in San Antonio. Theracle and iBridge Medical join three existing InCube San Antonio companies, Corhythm, Neurolink and Fe3...
New ICD device technology is changing the CRM market for a population with heart disease on the rise. Vancouver, Canada (PRWEB) April 16, 2013 Heart failure affects over five million people annually in the U.S., and is the most costly cardiovascular illness with upwards of $30 billion spent on managing it each year. According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the U.S. cardiac rhythm management (CRM),...
As hospitals work to monitor and reduce cardiac overutilization, peer review professionals are increasingly called upon to evaluate the medical necessity of procedures which are not always subjected to traditional utilization review. Portland, OR (PRWEB) March 20, 2013 In a recent webinar hosted by AllMed Healthcare Management, Dr. Christopher Bonnet reviewed ACC and AHA Class I and Class IIa recommendations for cardiac pacemakers and antiarrhythmia devices. Once considered a treatment of...
Association of Black Cardiologists, Heart Rhythm Society, and the Monarch Awards Foundation Partner to Raise Awareness and Help Prevent Heart Condition Disproportionately Impacting African Americans CHICAGO, March 18, 2013 /PRNewswire/ -- To help Chicago residents understand their risk for sudden cardiac arrest (SCA), the Heart Rhythm Society (HRS), Association of Black Cardiologists (ABC), and the Monarch Awards Foundation are hosting an education event urging consumers,...
redOrbit Staff & Wire Reports - Your Universe Online Good news for those who require implanted cardiac devices to lower the risk of sudden death from heart attacks but still want to help out the environment when they’re behind the wheel of an automobile – driving a hybrid or electric car will not adversely affect a person’s cardiac implant. Researchers at the Mayo Clinic in Arizona report that they have discovered no evidence suggesting that hybrid or full-electric vehicles...
New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat irregular heart rhythms, leaving them misinformed about how the device may affect quality of life. The article, titled 'Patient Perceptions, Physician Communication and the Implantable Cardioverter-Defibrillator,' was published online in JAMA Internal Medicine (formerly Archives of Internal Medicine) on...
